B. Joseph Guglielmo, PharmD

Dean Emeritus

B. Joseph Guglielmo, PharmD, is a pharmacist, clinical scientist, teacher, and international expert in the evidence-based use of antimicrobials to treat infections.

He was named dean of the UCSF School of Pharmacy in 2012 and holds the Troy C. Daniels Distinguished Professorship in Pharmaceutical Science.

As dean, Guglielmo oversees the activities and progress of three departments; a campus organized research unit; and a dean’s office charged with School administration and finance, strategic planning, communications, academic affairs, and the development and delivery of a doctor of pharmacy (PharmD) degree program. His leadership as dean actively supports the distinguishing UCSF concept of One UCSF and upholds the institution’s PRIDE values.

During his tenure as dean, the School of Pharmacy has remained the top recipient among pharmacy schools nationwide of research dollars from the National Institutes of Health (NIH), and its PharmD degree program has remained among the top-rated such programs in the nation.

Guglielmo initiated a transformation of the PharmD degree program, which welcomed its first class in 2018. The program’s foundation of scientific thinking evolves from the distinctive scientific mindset of the faculty, and the faculty’s drive to seek and apply new knowledge across research, education, and patient care.

Guglielmo is widely known as an advocate for therapeutics-related research, from basic science to health policy research. As chair of the School's Department of Clinical Pharmacy, Guglielmo oversaw a 40 percent increase in the Department of Clinical Pharmacy’s faculty research funding. He created the department-run Medication Outcomes Center in 2007 to improve medication use at UCSF Health and beyond. In the late 1980s he developed the UCSF Medical Center Antimicrobial Stewardship Program to ensure the safe, effective use of antimicrobials, focusing upon decreasing antimicrobial resistance. The program was one of the earliest programs of its kind in the United States.

As patients seek new and cost-effective health care with increasingly complicated disease states and medications, Guglielmo advocates for research on new ways for pharmacists to care for patients, especially in the community. He also supports strong relationships among clinical scientists and their upstream basic and translational scientist colleagues, as demonstrated through his own collaborations. Guglielmo has been actively involved in the UCSF Clinical and Translational Science Institute (CTSI) from its inception and during its renewal; he has also served as past associate director of the CTSI Mentor Development Program.

His personal research agenda involves the safe, effective, and appropriate use of antimicrobials, as well as the pharmacoepidemiology and pharmacokinetics of anti-infective agents. He is the author of numerous peer-reviewed papers, book chapters, and abstracts, the majority related to anti-infective agents.

He believes that the most important clinical research is shaped through the researcher’s own clinical experiences. Together with his administrative, research, and teaching responsibilities, he continues to be active as an infectious diseases pharmacist supporting the UCSF Medical Center Antimicrobial Stewardship Program and serving on the Infectious Diseases Consult Service team. These experiences continue to provide the background for important hypothesis-centered research on the safe, effective use of antimicrobials.

Beyond the hospital, Guglielmo developed clinical pharmacy services for UCSF HIV/AIDS programs, specifically for the HIV Women's Program and the Men of Color Program.

Guglielmo has taught doctor of pharmacy students, pharmacy residents and fellows, medical students and residents, and infectious diseases fellows for decades, and he has mentored infectious diseases specialty pharmacist residents and fellows continuously since 1986. He has also mentored a number of international scholars, including Fogarty fellows.

He is the recipient of many teaching awards, including the UCSF Lifetime Achievement in Mentoring Award, Resident Preceptor of the Year Awards, UCSF School of Pharmacy Long Teaching Awards, and UCSF Academic Senate Distinction in Teaching Award. He is a fellow of the American College Clinical Pharmacy and the Infectious Diseases Society of America.


Guglielmo earned a PharmD from the University of Southern California in 1978 and completed a PharmD residency at UCSF in 1979.

Education
Residency, 1979 - School of Pharmacy - Pharmacy Practice, University of California, San Francisco
PharmD, 1978 - Pharmacy, University of Southern California (USC)
B.S., 1973 - Biology, Santa Clara University
Honors and Awards
  • Fellow, Infectious Diseases Society America, 2013
  • Troy C. Daniels Distinguished Professorship in Pharmaceutical Science, UCSF, 2013
  • Fellow, American College of Clinical Pharmacy, 2011
  • Faculty Mentoring Program Lifetime Achievement in Mentoring Award, UCSF, 2010
  • Vincent G. Pons Award in Clinical Infectious Diseases, UCSF, 2005
  • Long Prize for Excellence in Teaching, UCSF, 1999
  • Pharmacy Leadership Society Recognition, Phi Lambda Sigma, 1995
  • Pharmacy Residents Preceptorship Award, UCSF, 1995
  • Fellow, California Society of Health-System Pharmacists, 1993
  • Academic Senate Distinction in Teaching Award, UCSF, 1992
  • Commencement Speaker, School of Pharmacy, UCSF, 1992
  • Pharmacy Residents Preceptorship Award, UCSF, 1989
  • Pharmacy Residents Preceptorship Award, UCSF, 1988
  • Pharmacy Residents Preceptorship Award, UCSF, 1987
  • Long Foundation Award for Excellence in Teaching, UCSF, 1986
  • Pharmacy Residents Preceptorship Award, UCSF, 1985
  • Long Foundation Award for Excellence in Teaching, UCSF, 1981
  • Pharmacy Residents Preceptorship Award, UCSF, 1981
Websites
Publications

  1. Guglielmo BJ. Metronidazole neurotoxicity: suspicions confirmed. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020. PMID: 32266372


  2. Guglielmo BJ. The Colchicine Debacle Revisited. 2021. PMID: 33252611


  3. Guglielmo BJ. The Cost of Pharmaceutical Company Detailing Visits and Medication Samples. JAMA internal medicine 2020. PMID: 31985770


  4. Meyer-Massetti C, Hofstetter V, Hedinger-Grogg B, Meier CR, Guglielmo BJ. Medication-related problems during transfer from hospital to home care: baseline data from Switzerland. International journal of clinical pharmacy 2018. PMID: 30291577


  5. Meyer-Massetti C, Meier CR, Guglielmo BJ. The scope of drug-related problems in the home care setting. International journal of clinical pharmacy 2018. PMID: 29322475


  6. Woldu H, Guglielmo BJ. Incidence and risk factors for vancomycin nephrotoxicity in acutely ill pediatric patients J Pharm Technol 2018. PMID:


  7. Woldu H, Guglielmo BJ. Incidence and Risk Factors for Vancomycin Nephrotoxicity in Acutely Ill Pediatric Patients. 2017. PMID: 34860973


  8. Roy SL, Atkins JT, Gennuso R, Kofos D, Sriram RR, Dorlo TP, Hayes T, Qvarnstrom Y, Kucerova Z, Guglielmo BJ, Visvesvara GS. Assessment of blood-brain barrier penetration of miltefosine used to treat a fatal case of granulomatous amebic encephalitis possibly caused by an unusual Balamuthia mandrillaris strain. Parasitology research 2015. PMID: 26329128


  9. Cheng CM, Shin J, Guglielmo BJ. Trends in boxed warnings and withdrawals for novel therapeutic drugs, 1996 through 2012. JAMA internal medicine 2014. PMID: 25127107


  10. Hardmeier A, Tsourounis C, Moore M, Abbott WE, Guglielmo BJ. Pediatric medication administration errors and workflow following implementation of a bar code medication administration system. Journal for healthcare quality : official publication of the National Association for Healthcare Quality 2014. PMID: 25041604


  11. Gahbauer AM, Gonzales ML, Guglielmo BJ. Patterns of antibacterial use and impact of age, race/ethnicity, and geographic region on antibacterial use in an outpatient medicaid cohort. Pharmacotherapy 2014. PMID: 24753176


  12. Tan M, Lau J, Guglielmo BJ. Ethanol locks in the prevention and treatment of catheter-related bloodstream infections. The Annals of pharmacotherapy 2014. PMID: 24554477


  13. Frymoyer A, Guglielmo BJ, Hersh AL. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections. The Pediatric infectious disease journal 2013. PMID: 23652479


  14. Frymoyer A, Lee S, Bonifacio SL, Meng L, Lucas SS, Guglielmo BJ, Sun Y, Verotta D. Every 36-h gentamicin dosing in neonates with hypoxic-ischemic encephalopathy receiving hypothermia. Journal of perinatology : official journal of the California Perinatal Association 2013. PMID: 23702622


  15. Gwaza L, Aweeka F, Greenblatt R, Lizak P, Huang L, Guglielmo BJ. Co-administration of a commonly used Zimbabwean herbal treatment (African potato) does not alter the pharmacokinetics of lopinavir/ritonavir. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2013. PMID: 23587599


  16. Frymoyer A, Meng L, Bonifacio SL, Verotta D, Guglielmo BJ. Gentamicin pharmacokinetics and dosing in neonates with hypoxic ischemic encephalopathy receiving hypothermia. Pharmacotherapy 2013. PMID: 23553582


  17. Burrell C, Tsourounis C, Quan D, Jue V, Tam E, Guglielmo BJ. Impact of a pharmacist-driven protocol to improve drug allergy documentation at a university hospital. Hospital pharmacy 2013. PMID: 24421479


  18. Guglielmo BJ. The colchicine debacle. JAMA internal medicine 2013. PMID: 23277277


  19. Cocohoba JM, Murphy P, Pietrandoni G, Guglielmo BJ. Improved antiretroviral refill adherence in HIV-focused community pharmacies. Journal of the American Pharmacists Association : JAPhA 2012. PMID: 23023860


  20. Murphy P, Cocohoba J, Tang A, Pietrandoni G, Hou J, Guglielmo BJ. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. AIDS patient care and STDs 2012. PMID: 22860900


  21. Swartling M, Gupta R, Dudas V, Guglielmo BJ. Short term impact of guidelines on vancomycin dosing and therapeutic drug monitoring. International journal of clinical pharmacy 2012. PMID: 22331444


  22. Cheng CM, Fu C, Guglielmo BJ, Auerbach AD. Boxed warning inconsistencies between drug information resources and the prescribing information. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2011. PMID: 21856808


  23. Frymoyer A, Guglielmo BJ, Wilson SD, Scarpace SB, Benet LZ, Hersh AL. Impact of a hospitalwide increase in empiric pediatric vancomycin dosing on initial trough concentrations. Volume 31 of Issue 9. Pharmacotherapy 2011. PMID: 21923588


  24. Guglielmo BJ, Edwards DJ, Franks AS, Naughton CA, Schonder KS, Stamm PL, Thornton P, Popovich NG. A critical appraisal of and recommendations for faculty development. American journal of pharmaceutical education 2011. PMID: 21931460


  25. Meyer-Massetti C, Vaerini S, Rätz Bravo AE, Meier CR, Guglielmo BJ. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case. International journal of clinical pharmacy 2011. PMID: 21809143


  26. Cheng C, Guglielmo BJ. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling". Archives of internal medicine 2011. PMID: 21606102


  27. Meyer-Massetti C, Cheng CM, Schwappach DL, Paulsen L, Ide B, Meier CR, Guglielmo BJ. Systematic review of medication safety assessment methods. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2011. PMID: 21258028


  28. Macdougall C, Udkow T, Guglielmo BJ, Vittinghoff E, Martin J. National estimates and predictors of prescription medication sample use in the United States, 1999-2005. Volume 50 of Issue 6. Journal of the American Pharmacists Association : JAPhA 2010. PMID: 21071311


  29. Sohn AH, Schwartz JM, Yang KY, Jarvis WR, Guglielmo BJ, Weintrub PS. Risk factors and risk adjustment for surgical site infections in pediatric cardiothoracic surgery patients. American journal of infection control 2010. PMID: 20605267


  30. Guglielmo BJ. A prescription for improved chronic disease management: have community pharmacists function at the top of their training: comment on "Engaging physicians and pharmacists in providing smoking cessation counseling". Archives of internal medicine 2010. PMID: 20937923


  31. Cheng CM, Guglielmo BJ, Maselli J, Auerbach AD. Coverage of FDA medication boxed warnings in commonly used drug information resources. Archives of internal medicine 2010. PMID: 20458094


  32. Nakamura K, Schwartz BS, Lindegårdh N, Keh C, Guglielmo BJ. Possible neuropsychiatric reaction to high-dose oseltamivir during acute 2009 H1N1 influenza A infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010. PMID: 20192728


  33. Meyer-Massetti C, Cheng CM, Sharpe BA, Meier CR, Guglielmo BJ. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? Journal of hospital medicine 2010. PMID: 20394022


  34. Koplowicz YB, Schwartz BS, Guglielmo BJ. Development of daptomycin-susceptible, methicillin-resistant Staphylococcus aureus pneumonia during high-dose daptomycin therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009. PMID: 19780665


  35. Martin T, Sharma M, Damon L, Kaplan L, Guglielmo BJ, Working M, O'Malley R, Hwang J, Linker C. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society 2009. PMID: 19793068


  36. Feldman MD, Huang L, Guglielmo BJ, Jordan R, Kahn J, Creasman JM, Wiener-Kronish JP, Lee KA, Tehrani A, Yaffe K, Brown JS. Training the next generation of research mentors: the University of California, San Francisco, Clinical & Translational Science Institute Mentor Development Program. Clinical and translational science 2009. PMID: 19774102


  37. Frymoyer A, Hersh AL, Benet LZ, Guglielmo BJ. Current recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate. Volume 28 of Issue 5. The Pediatric infectious disease journal 2009. PMID: 19295465


  38. Yang K, Zhuo H, Guglielmo BJ, Wiener-Kronish J. Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures. The Annals of pharmacotherapy 2008. PMID: 19033484


  39. Marquez C, Guglielmo BJ, Klausner JD. Five years later: re-examining the financial burden of boosting with Norvir. AIDS (London, England) 2008. PMID: 18981784


  40. Patel D, Lawson W, Guglielmo BJ. Antimicrobial stewardship programs: interventions and associated outcomes. Expert review of anti-infective therapy 2008. PMID: 18380603


  41. Frenzel T, Lee CZ, Kim H, Quinnine NJ, Hashimoto T, Lawton MT, Guglielmo BJ, McCulloch CE, Young WL. Feasibility of minocycline and doxycycline use as potential vasculostatic therapy for brain vascular malformations: pilot study of adverse events and tolerance. Cerebrovascular diseases (Basel, Switzerland) 2008. PMID: 18212521


  42. Schwartz BS, Ngo PD, Guglielmo BJ. Daptomycin treatment failure for vancomycin-resistant Enterococcus faecium infective endocarditis: impact of protein binding? The Annals of pharmacotherapy 2008. PMID: 18172014


  43. Robinson CA, Cocohoba J, MacDougall C, John MD, Guglielmo BJ. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. Volume 47 of Issue 5. Journal of the American Pharmacists Association : JAPhA 2007. PMID: 17848351


  44. Yang K, Guglielmo BJ. Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms. The Annals of pharmacotherapy 2007. PMID: 17666573


  45. Riedel A, Choe L, Inciardi J, Yuen C, Martin T, Guglielmo BJ. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study. BMC infectious diseases 2007. PMID: 17605773


  46. Nicandro JP, Tsourounis C, Frassetto L, Guglielmo BJ. In vivo effect of I'm-Yunity on hepatic cytochrome P450 3A4. Journal of herbal pharmacotherapy 2007. PMID: 17594986


  47. Huang Y, Okochi H, May BC, Legname G, Prusiner SB, Benet LZ, Guglielmo BJ, Lin ET. Quinacrine is mainly metabolized to mono-desethyl quinacrine by CYP3A4/5 and its brain accumulation is limited by P-glycoprotein. Volume 34 of Issue 7. Drug metabolism and disposition: the biological fate of chemicals 2006. PMID: 16581945


  48. Schuster FL, Guglielmo BJ, Visvesvara GS. In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri. The Journal of eukaryotic microbiology 2006. PMID: 16579814


  49. Deck DH, Guglielmo BJ. Pharmacological advances in the treatment of invasive candidiasis. Expert review of anti-infective therapy 2006. PMID: 16441215


  50. Lee CZ, Yao JS, Huang Y, Zhai W, Liu W, Guglielmo BJ, Lin E, Yang GY, Young WL. Dose-response effect of tetracyclines on cerebral matrix metalloproteinase-9 after vascular endothelial growth factor hyperstimulation. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2006. PMID: 16395286


  51. Mendez MN, Gibbs L, Jacobs RA, McCulloch CE, Winston L, Guglielmo BJ. Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections. Pharmacotherapy 2006. PMID: 16509027


  52. Guglielmo BJ, Dudas V, Maewal I, Young R, Hilts A, Villmann M, Gibbs L, Gropper M, Jacobs R. Impact of a series of interventions in vancomycin prescribing on use and prevalence of vancomycin-resistant enterococci. Joint Commission journal on quality and patient safety 2005. PMID: 16156195


  53. MacDougall C, Guglielmo BJ, Maselli J, Gonzales R. Antimicrobial drug prescribing for pneumonia in ambulatory care. Volume 11 of Issue 3. Emerging infectious diseases 2005. PMID: 15757551


  54. Chang NN, Murray CK, Houck PM, Bratzler DW, Greenway C, Guglielmo BJ. Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia. Pharmacotherapy 2005. PMID: 15767221


  55. Yung L, Huang Y, Lessard P, Legname G, Lin ET, Baldwin M, Prusiner SB, Ryou C, Guglielmo BJ. Pharmacokinetics of quinacrine in the treatment of prion disease. BMC infectious diseases 2004. PMID: 15569390


  56. Killgore KM, March KL, Guglielmo BJ. Risk factors for community-acquired ciprofloxacin-resistant Escherichia coli urinary tract infection. The Annals of pharmacotherapy 2004. PMID: 15150380


  57. MacDougall C, Guglielmo BJ. Pharmacokinetics of valaciclovir. Volume 53 of Issue 6. The Journal of antimicrobial chemotherapy 2004. PMID: 15140857


  58. Bower AN, Tang HM, Guglielmo BJ. Compliance in two medical centers with criteria for use of caspofungin and lipid-based amphotericin B. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2004. PMID: 15156967


  59. Oren E, Shaffer ER, Guglielmo BJ. Impact of emerging technologies on medication errors and adverse drug events. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2003. PMID: 12892029


  60. Phan DD, Chin-Hong P, Lin ET, Anderle P, Sadee W, Guglielmo BJ. Intra- and interindividual variabilities of valacyclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor. Antimicrobial agents and chemotherapy 2003. PMID: 12821497


  61. Hickman DE, Stebbins MR, Hanak JR, Guglielmo BJ. Pharmacy-based intervention to reduce antibiotic use for acute bronchitis. The Annals of pharmacotherapy 2003. PMID: 12549944


  62. Oren E, Griffiths LP, Guglielmo BJ. Characteristics of antimicrobial overrides associated with automated dispensing machines. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2002. PMID: 12166045


  63. Yang K, Guglielmo BJ. Patient education for H pylori: who benefits? The Western journal of medicine 2002. PMID: 11897729


  64. Graff LR, Franklin KK, Witt L, Cohen N, Jacobs RA, Tompkins L, Guglielmo BJ. Antimicrobial therapy of gram-negative bacteremia at two university-affiliated medical centers. The American journal of medicine 2002. PMID: 11893347


  65. Botwin KJ, Chan J, Jacobs R, Guglielmo BJ. Restricted access to automated dispensing machines for surgical antimicrobial prophylaxis. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2001. PMID: 11351920


  66. Burkiewicz JS, Kostiuk KA, Jacobs RA, Guglielmo BJ. Impact of an intravenous fluconazole restriction policy on patient outcomes. The Annals of pharmacotherapy 2001. PMID: 11197590


  67. Dudas V, Hopefl A, Jacobs R, Guglielmo BJ. Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals. The Annals of pharmacotherapy 2000. PMID: 10772428


  68. Guglielmo BJ, Luber AD, Paletta D, Jacobs RA. Ceftriaxone therapy for staphylococcal osteomyelitis: a review. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2000. PMID: 10619757


  69. Guglielmo BJ, Luber AD, Corelli RL, Flaherty JF, Jacobs RA. Prevention of adverse events in hospitalized patients using an antimicrobial review program. The Western journal of medicine 1999. PMID: 10560287


  70. Luber AD, Maa L, Lam M, Guglielmo BJ. Risk factors for amphotericin B-induced nephrotoxicity. The Journal of antimicrobial chemotherapy 1999. PMID: 11252333


  71. Guglielmo BJ. Use of antimicrobial agents in patients with cardiovascular disease. The Journal of cardiovascular nursing 1999. PMID: 9888061


  72. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Lipid formulations of amphotericin B: clinical efficacy and toxicities. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998. PMID: 9770163


  73. Guglielmo BJ, Kostiuk KA, Pons VG. Pharmacokinetics and pharmacodynamics of ceftizoxime in abscess fluid. The Journal of antimicrobial chemotherapy 1997. PMID: 9096200


  74. Hashimoto S, Wolfe E, Guglielmo B, Shanks R, Sundelof J, Pittet JF, Thomas E, Wiener-Kronish J. Aerosolization of imipenem/cilastatin prevents pseudomonas-induced acute lung injury. The Journal of antimicrobial chemotherapy 1996. PMID: 8961050


  75. Barlows TG, Luber AD, Jacobs RA, Guglielmo BJ. Hypothermia following the intravenous administration of amphotericin B. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996. PMID: 8922832


  76. Tsourounis C, Guglielmo BJ. Aerosolized amphotericin B in prophylaxis of pulmonary aspergillosis. The Annals of pharmacotherapy 1996. PMID: 8893125


  77. Guglielmo BJ, Jacobs RA. Impact of dosage-monitoring system on frequency of seizures associated with imipenem-cilastatin. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 1996. PMID: 8870902


  78. Guglielmo BJ, Quan LA, Stulbarg MS. Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients. The Journal of antimicrobial chemotherapy 1996. PMID: 8737161


  79. Luber AD, Jacobs RA, Jordan M, Guglielmo BJ. Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin-resistant enterococci. The Journal of infectious diseases 1996. PMID: 8627091


  80. Guglielmo BJ. Practical strategies for the appropriate use of antimicrobials. Pharmacy world & science : PWS 1995. PMID: 7581222


  81. Wong-Beringer A, Corelli RL, Schrock TR, Guglielmo BJ. Influence of timing of antibiotic administration on tissue concentrations during surgery. American journal of surgery 1995. PMID: 7694975


  82. Singh RF, Corelli RL, Guglielmo BJ. Sterility of unit dose syringes of filgrastim and sargramostim. American journal of hospital pharmacy 1994. PMID: 7531941


  83. Kostiuk KA, Pons VG, Guglielmo BJ. Penetration of fluconazole into abscess fluid. The Journal of antimicrobial chemotherapy 1994. PMID: 7868415


  84. Guglielmo BJ, Wong-Beringer A, Linker CA. Immune globulin therapy in allogeneic bone marrow transplant: a critical review. Bone marrow transplantation 1994. PMID: 8054903


  85. Joe LA, Jacobs RA, Guglielmo BJ. Systemic absorption of oral fluconazole after gastrointestinal resection. The Journal of antimicrobial chemotherapy 1994. PMID: 8089060


  86. Kanatani MS, Guglielmo BJ. The new macrolides. Azithromycin and clarithromycin. The Western journal of medicine 1994. PMID: 8128699


  87. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Nosocomial funguria: resultant morbidity and therapeutic intervention. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993. PMID: 8110936


  88. Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB. Ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis: a randomized, prospective, blinded clinical study. Neurosurgery 1993. PMID: 8413872


  89. Pons VG, Denlinger SL, Guglielmo BJ, Octavio J, Flaherty J, Derish PA, Wilson CB. Comment; ceftizoxime versus vancomycin and gentamicin in neurosurgical prophylaxis. Neurosurgery 1993. PMID: 8413895


  90. Colford JM, Corelli RL, Ganz JW, Guglielmo BJ, Jacobs RA. Home antibiotic therapy for streptococcal endocarditis: a call for a controlled trial. The American journal of medicine 1993. PMID: 8420289


  91. Wong-Beringer A, Jacobs RA, Guglielmo BJ. Treatment of funguria. JAMA 1992. PMID: 1578598


  92. Barriere SL, Guglielmo BJ. Gram-negative sepsis, the sepsis syndrome, and the role of antiendotoxin monoclonal antibodies. Clinical pharmacy 1992. PMID: 1611812


  93. Corelli RL, Guglielmo BJ, Kapusnik-Uner JE, McMaster JR, Greenblatt RM. Medication usage patterns in patients with human immunodeficiency virus infection: a comparison of patient-reported medication usage with medical chart review. DICP : the annals of pharmacotherapy 1991. PMID: 1815436


  94. Glick PL, Guglielmo BJ, Winter ME, Finkbeiner W, Turley K. Iodine toxicity secondary to continuous povidone-iodine mediastinal irrigation in dogs. The Journal of surgical research 1990. PMID: 2246887


  95. Glick M, Guglielmo BJ. Antibiotic prophylaxis in cesarean section. DICP : the annals of pharmacotherapy 1990. PMID: 2260343


  96. Hebert MF, Guglielmo BJ. What is the clinical role of aerosolized ribavirin? DICP : the annals of pharmacotherapy 1990. PMID: 2197815


  97. Guglielmo BJ, Brooks GF. Antimicrobial therapy. Cost-benefit considerations. Drugs 1989. PMID: 2510985


  98. Brodowy BA, Guglielmo BJ, York MK, Herfindal ET, Brooks GF. Experience with selective reporting of susceptibility to antimicrobial agents. American journal of hospital pharmacy 1989. PMID: 2801717


  99. Tam J, Guglielmo BJ. Microbiology and antibiotics in infectious abdominal emergencies. Emergency medicine clinics of North America 1989. PMID: 2663459


  100. Guglielmo BJ, Schweigert BF, Kishi DT. Pharmacist-managed drug therapy in California hospitals. American journal of hospital pharmacy 1989. PMID: 2757041


  101. Sue D, Salazar TA, Turley K, Guglielmo BJ. Effect of surgical blood loss and volume replacement on antibiotic pharmacokinetics. The Annals of thoracic surgery 1989. PMID: 2757440


  102. Oliva SL, Guglielmo BJ, Jacobs R, Pons VG. Failure of intravenous vancomycin and intravenous metronidazole to prevent or treat antibiotic-associated pseudomembranous colitis. The Journal of infectious diseases 1989. PMID: 2491408


  103. Guglielmo BJ, Jacobs RA, Locksley RM. The exposure of health care workers to ribavirin aerosol. JAMA 1989. PMID: 2926922


  104. Guglielmo BJ, Salazar TA, Rodondi LC, Carver M, Goldstone J, Stoney RJ. Altered pharmacokinetics of antibiotics during vascular surgery. American journal of surgery 1989. PMID: 2929864


  105. Dugoni BM, Guglielmo BJ, Hollander H. Amphotericin B concentration in cerebrospinal fluid of patients with AIDS and cryptococcal meningitis. Clinical pharmacy 1989. PMID: 2706895


  106. Flaherty JF, Rodondi LC, Guglielmo BJ, Fleishaker JC, Townsend RJ, Gambertoglio JG. Comparative pharmacokinetics and serum inhibitory activity of clindamycin in different dosing regimens. Antimicrobial agents and chemotherapy 1988. PMID: 3245695


  107. Guglielmo BJ, Rodondi LC. Comparison of antibiotic activities by using serum bactericidal activity over time. Antimicrobial agents and chemotherapy 1988. PMID: 3056237


  108. Lam YW, Duroux MH, Gambertoglio JG, Barriere SL, Guglielmo BJ. Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteers. Antimicrobial agents and chemotherapy 1988. PMID: 3284457


  109. R.J. Harrison, J. Bellows, D. Rempel, L. Rudolph, K. Kizer, A. Jin, B.J. Guglielmo. Assessing Exposures of Health-care Personnel to Aerosols of Ribavirin-California Morbidity and Mortality Weekly Reports 1988. PMID:


  110. B.J. Guglielmo and L.C. Rodondi. Comparison of Antibiotic Activity Using Serum Bactericidal Activity Over Time Antimicrob. Agents Chemother 1988. PMID:


  111. Y.W.F. Lam, M.H. Duroux, J.G. Gambertoglio, S.L. Barriere, and B.J. Guglielmo. Effect of Protein Binding on Serum Bactericidal Activities of Ceftazidime and Cefoperazone in Healthy Volunteers Antimicrob. Agents Chemother9. Effect of Protein Binding on Serum Bactericidal Activities of Ceftazidime and Cefoperazone in Healthy Volunteers 1988. PMID:


  112. P.A. Arnold, B.J. Guglielmo, and H. Hollander. Severe Hypersensitivity Reaction Upon Rechallenge With Trimethoprim-sulfamethoxazole in a Patient With AIDS Drug Intell. Clin. Pharm. 22, 43-45 (1988). 1988. PMID:


  113. Arnold PA, Guglielmo BJ, Hollander H. Severe hypersensitivity reaction upon rechallenge with trimethoprim-sulfamethoxazole in a patient with AIDS. Drug intelligence & clinical pharmacy 1988. PMID: 2965002


  114. M.J. Mahlmeister, B.J. Guglielmo, and R. Harrison. We are Concerned About Ribavirin Exposure Resp. Care 1988. PMID:


  115. Guglielmo BJ, Flaherty JF, Woods TM, LaFollette G, Gambertoglio JG. Pharmacokinetics of cefoperazone and tobramycin alone and in combination. Antimicrobial agents and chemotherapy 1987. PMID: 3566252


  116. B.J. Guglielmo, J.F. Flaherty, T.M. Woods, G. LaFollette, and J.G. Gambertoglio. Pharmacokinetics of Cefoperazone and Tobramycin Alone and in Combination Antimicrob. Ag. Chemother 1987. PMID:


  117. Guglielmo BJ, Flaherty JF, Batman R, Barriere SL, Gambertoglio JG. Comparative pharmacokinetics of low- and high-dose ticarcillin. Antimicrobial agents and chemotherapy 1986. PMID: 3777901


  118. B.J. Guglielmo, J.F. Flaherty, R. Batman, S.L. Barriere, and J.G. Gambertoglio. Comparative Pharmacokinetics of Low- and High-Dose Ticarcillin Antimicrob. Ag. Chemother 1986. PMID:


  119. Glick PL, Guglielmo BJ, Tranbaugh RF, Turley K. Iodine toxicity in a patient treated by continuous povidone-iodine mediastinal irrigation. The Annals of thoracic surgery 1985. PMID: 3994451


  120. P.L. Glick, B.J. Guglielmo, R.F. Tranbaugh, and K. Turley. Iodine Toxicity in a Patient Treated by Continuous Povidone-Iodine Mediastinal Irrigation Ann. Thorac. Surg 1985. PMID:


  121. B.J. Guglielmo, D.C. Hohn, P.J. Koo, T.K. Hunt, R.C. Sweet, and J.E. Conte. Antibiotic Prophylaxis in Surgical Procedures. A Critical Analysis of the Literature Arch. Surg 1983. PMID:


  122. W.A. Kehoe and B.J. Guglielmo. Excessive Potassium Depletion with Metolazone and Furosemide Clin. Pharm 1983. PMID:


  123. B.D. Quart and B.J. Guglielmo. Prolonged Diarrhea Secondary to Methyldopa Therapy Drug Intell. Clin. Pharm 1983. PMID:


  124. Brown KR, Guglielmo BJ, Pons VG, Jacobs RA. Theophylline elixir, moxalactam, and a disulfiram reaction. Annals of internal medicine 1982. PMID: 6214982


  125. K.R. Brown, B.J. Guglielmo, V.G. Pons, and R.A. Jacobs. Theophylline Elixir, Moxalactam, and a Disulfiram Reaction Ann. Int. Med. 1982. PMID: